Table 1. Study participant (n = 152) characteristics at breast cancer diagnosis.
See supplemental online Appendix 1 for chemotherapy regimens by breast cancer phenotype.
See supplemental online Appendix 2 for further details regarding chemotherapy drug combinations.
See supplemental online Appendix 4 for clinician notes regarding reasons associated with chemotherapy adverse events.
Abbreviations: AJCC, American Joint Committee on Cancer; BMI, body mass index; HER2+, HER2‐positive; HER2−, HER2‐negative; HR+, hormone receptor positive; HR−, hormone receptor negative.